FindTrial
Sign In

The physical and mental outcomes between hysterectomy and uterus-sparing treatment for benign uterine diseases: a prospective cohort study

The physical and mental outcomes between hysterectomy and uterus-sparing treatment for benign uterine diseases: a prospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200067096
Enrollment
Unknown
Registered
2022-12-27
Start date
2022-12-31
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign uterine disease (uterine fibroids, adenomyosis ,abnormal uterine bleeding)

Interventions

Hysterectomy group:Hysterectomy
Non hysterectomy group:Other treatments

Sponsors

Nanchong Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.Premenopausal women with the age from 18 to 45. 2.Patients without pregnant. 3.Those with symptomatic uterine fibroids or adenomyosis or abnormal uterine bleeding. 4.Those without the history of ovarian, endocrine, or malignant tumor disease.

Exclusion criteria

Exclusion criteria: 1. Patients refuse or do not cooperate with the study 2. Those with the history of ovarian, endocrine, and other malignant tumors or diseases. 3. Those within menopause. 4. Those within pregnancy or during termination three months.

Design outcomes

Primary

MeasureTime frame
The serum E2 level;The serum AMH level;The serum FSH level;The serum LH level;—

Secondary

MeasureTime frame
EQ-5D-5L score;SF-12 score;MMSE score;Pelvic floor function;Sexual Function Score;SAS score;—

Countries

China

Contacts

Public ContactXu Fan

Nanchong Central Hospital

xufanyidingxin@163.com15984877283

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026